Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat

British Journal of Pharmacology

Volumn 133, Issue 4, 2001, Pages 495-502

  Arbin, V ^a   Claperon, N ^a   Fournie Zaluski M C ^b   Roques, B P ^b   Peyroux, J ^a  

^a INSERM   (France)

^b Laboratoire de Pharmacochimie   (France)

Author keywords

Angiotensin converting enzyme inhibitor; Bradykinin; Captopril, retrothiorphan; Insulin resistance whole body insulin mediated glucose disposal; Mixanpril; Neutral endopeptidase 24 11 inhibitor; Nitric oxide; Obese Zucker rat

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; ENKEPHALINASE INHIBITOR; ICATIBANT; KININ; MEMBRANE METALLOENDOPEPTIDASE; MIXANPRIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; RETROTHIORPHAN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; INSULIN SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034957092     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704098     Document Type: Article

References (40)

1. Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes
2. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats
3. Nitric oxide is present from incubated skeletal muscle
4. Rate and tissue sites of non insulin and insulin mediated glucose uptake in humans
5. Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats
6. Bioregulation of kinins: Kallikreins, kininogens and kininases
7. Insulin resistance in adipocytes from spontaneously hypertensive rats: Effect of long-term treatment with enalapril and losartan
8. Effect of captopril, losartan and bradykinin on early steps of insulin action
9. Angiotensin-converting enzyme inhibitor increases insulin-induced pp 185 phosphorylation in liver and muscle of obese rats
10. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids
11. Insulin sensitivity, clearance and release in kininogen-deficient rats
12. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart
13. Mechanisms of insulin resistance and new pharmacological approaches to metabolism and diabetic complications
14. Kininase II-type enzymes. Their putative role in muscle energy metabolism
15. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones
16. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: A potential therapeutic approach in hypertension
17. Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in over-weight hypertensive patients: Trandolapril Italian Study (TRIS)
18. ω-nitro-L-arginine methyl ester
19. Effects of the neutral endopeptidase inhibitor SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats
20. Comparative effects of the dual metallopeptidase inhibitor, MDL 100,240 and of enalaprilat on regional and on cardiac haemodynamics in conscious, hypertensive, transgenic ((mRen-2)27) rats
21. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats
22. Bradykinin degrading activity in cultured human endothelial cells
23. Degradation of bradykinin by neutral endopeptidase (EC 3.4.24.11) in cultured human endothelial cells
24. Bradykinin metabolism in rat hindlimbs
25. Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonista
26. ACE inhibition and glucose transport in insulin-resistant muscle. Role of bradykinin and nitric oxide
27. Effect of captopril on glucose concentration. Possible role of augmented postprandial forearm blood flow
28. Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats
29. Effects of quinapril and losartan on insulin sensitivity in genetic hypertensive rats with different metabolic abnormalities
30. Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat
31. Effect of endopeptidase 24-11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide
32. Effects of the selective NEP inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats
33. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension
34. Bradykinin B2 receptors on skeletal muscle are coupled to inositol 1,4,5-triphosphate formation
35. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retrothiorphan
36. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent
37. Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin-converting enzyme inhibitor
38. Effect on insulin sensitivity of angiotensin-converting enzyme inhibitors with or without a sulphydryl group: Bradykinin may improve insulin resistance in dogs and humans
39. Measurement of glucose concentrations in rats: Differences between glucose meter and plasma laboratory results
40. NO-mediated vasodilatation in the rat liver. Role of hepatocytes and liver endothelial cells